Tag: tamoxifenResistant
Articles
- ER+/PR- breast cancer
- Latest research concerning impact of endocrine therapy on breast cancer prognosis
- What should breast cancer patients and survivors eat during tamoxifen treatment?
News
- Although similar, ER+/PR- breast cancer is more aggressive than ER+/PR+
- Apigenin increases effectiveness of Taxol chemotherapy
- Breast cancer type and survival statistics 1999-2004
- Enhance tamoxifen treatment and reduce tamoxifen resistance with HDAC inhibitors
- Green tea compound EGCG has anti-cancer effects in tamoxifen-resistant breast cancer cells
- Green tea polyphenol EGCG slows development of tamoxifen resistance
- High intake of soy isoflavones increases risk of recurrence in HER2+ patients
- Omega-6 rich corn oil reduces effectiveness of tamoxifen
Foods
Studies
- (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line
- A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative
- Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression
- Effects of dietary omega-3 and omega-6 in the prevention of rat mammary cancer with tamoxifen
- Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation
- Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells
- Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells
- Molecular Signaling Distinguishes Early ER Positive Breast Cancer Recurrences Despite Adjuvant Tamoxifen
- Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells
- Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
- Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells
- Selenium disrupts estrogen receptor signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells
- The Effect of the Phytoestrogens Genistein, Daidzein, and Equol on the Growth of Tamoxifen-Resistant T47D/PKCα